Patrick Thomare
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.
Journal: European journal of dermatology : EJD
Published: July 11, 2023
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study.
Journal: Annals of hematology
Published: January 24, 2019
Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases.
Journal: Leukemia research reports
Published: December 08, 2017
Production and stability study of a hospital parenteral nutrition solution for neonates.
Journal: Journal of pharmaceutical analysis
Published: October 30, 2017
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.
Journal: Annals of hematology
Published: October 27, 2016
Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 06, 2015
Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma.
Journal: Haematologica
Published: February 18, 2014
Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (Observatoire dédié au Cancer Bretagne / Pays de la Loire).
Journal: Oncologie (Paris, France)
Published: October 17, 2013
Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort study.
Journal: Leukemia & lymphoma
Published: July 02, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026